Related Experiment Video
Updated: May 29, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Cyanotic congenital heart disease. Part 1]
1Department of Pediatric and Congenital Cardiovascular Surgery, Jichi Children's Medical Center Tochigi, Shimotsuke, Japan.
Insights
This review covers cyanotic complex congenital heart diseases like TGA and HLHS, focusing on early-life interventions and surgical outcomes. Advances in repair techniques aim to improve long-term survival for these critical conditions.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Surgery
- Neonatal Medicine
Context:
- Cyanotic complex congenital heart diseases often manifest in neonates and infants.
- Many require ductal dependency for survival, necessitating timely intervention.
- Key conditions discussed include TGA, TAPVC, PPA/PPS, and HLHS.
Purpose:
- To review current surgical strategies and outcomes for major cyanotic congenital heart diseases.
- To highlight advancements in repair techniques and their impact on patient survival.
- To discuss the challenges and future directions in managing these complex pediatric cardiac conditions.
Summary:
- Complete transposition of the great arteries (TGA) is often managed with the Jatene procedure, with good long-term results.
- Total anomalous pulmonary venous connection (TAPVC) repair shows good outcomes, with sutureless pericardial repair emerging to prevent complications.
- Hypoplastic left heart syndrome (HLHS) requires a staged approach, with innovations like the right ventricle-to-pulmonary artery conduit improving results.
- Pulmonary atresia/stenosis (PPA/PPS) management varies, with single ventricle physiology offering fair outcomes in many cases.
Impact:
- Improved surgical techniques and staged approaches are enhancing survival rates for complex congenital heart diseases.
- Ongoing research and innovation promise further refinements in treatment and long-term management.
- Early diagnosis and intervention remain critical for optimizing outcomes in affected infants.
Abstract:
This section deals with subgroups of cyanotic complex congenital heart diseases, most present early in life during neonatal period or early infancy. And some present with ductal dependency for survival. Here included are the complete transposition of the great arteries (TGA) [or Taussig-Bing anomaly] with/without aortic arch obstruction, total anomalous pulmonary venous connection (TAPVC), pure pulmonary atresia/stenosis (PPA/PPS) [pulmonary atresia with intact ventricular septum (PA/IVS) or critical pulmonary stenosis], hypoplastic left heart syndrome (HLHS) and its variants. In d-TGA cases except those with left ventricular outflow obstruction, primary Jatene procedure with/without concomitant repair of the aortic arch obstruction is the procedure of choice with good surgical and long-term results although acceptable rate of re-intervention is mandatory. In TAPVC, primary repair usually goes with good long-term result, although minority of the patients eventually develops for midable complication, postoperative pulmonary venous obstruction. Sutureless pericardial repair has been developed for coping with and later for prevention of this complication with promising mid-term results. Its introduction in primary repair especially in complex cases appears around the corner. HLHS and its variants has been the most challenging group of patients requiring staged approach starting with Norwood procedure or bilateral pulmonary artery banding. Right ventricle-to-pulmonary artery conduit, introduced as a Japanese innovation, has contributed marked improvement of surgical results although further refinements surely are necessary. Patients with PPA/PPS have a wide range of clinical pictures with intrinsic problems of right ventricle, tricuspid valve and associated coronary artery abnormalities. Adequate use of single ventricle physiology in many cases offers fair surgical results.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview
Cytomegalovirus Disease
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease I: Introduction

